Protein arginine methyltransferase crosstalk: decoding the synergistic-antagonistic axis in cancer therapy.
6 affiliations
- 1College of Medicine, Xi'an International University, Xi'an, 710077, China. [email protected].
- 2The Key Laboratory of Molecular Epigenetics of Ministry of Education (MOE), Northeast Normal University, Changchun, 130024, China. [email protected].
- 3The Key Laboratory of Molecular Epigenetics of Ministry of Education (MOE), Northeast Normal University, Changchun, 130024, China.
- 4School of Medicine, Xi'an Peihua University, Xi'an, 710125, China.
- 5Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, 250021, Shandong, China.
- 6School of life science, Northeast Normal University, Changchun, 130024, China.
Abstract
Background
Protein arginine methyltransferases (PRMTs) are abnormally expressed in various tumors and participate in multiple tumorigenic processes, including proliferation, metastasis, drug resistance, and metabolic reprogramming. However, in recent years, with the in-depth exploration of the functions of PRMTs and their associated tumorigenic mechanisms, the complex crosstalk relationships among different PRMTs have been increasingly highlighted. Different PRMTs may not only exhibit synergistic tumor-promoting effects but also demonstrate antagonistic effects in certain tumor biological functions. This makes the scientific and rational use of PRMT inhibitors a key factor for effective tumor suppression.Main body
The review aims to provide a comprehensive overview of the functional roles of different PRMTs in tumors, with a particular focus on their cross-functional regulatory mechanisms within the complex regulatory networks of tumors. Meanwhile, it summarizes the current research progress on PRMT inhibitors and elaborates on some limitations associated with PRMT-targeted therapy. Through the integration and analysis of existing research findings, this review offers a novel perspective on the complex regulatory roles of different PRMTs jointly participating in biological functions.Conclusions
Accumulating evidence suggests that implementing a multi-targeted intervention strategy for PRMTs and conducting stage-specific inhibition of PRMTs according to the progression stage of tumor development hold the potential to exert more significant therapeutic effects in the field of tumor treatment.
Related
- Antagonistic DNA methylation dynamics at a single locus controls pollen tube guidance in Arabidopsis
- The Lysine Methyltransferase SETDB1 Alleviates Methionine- and Choline-Deficient Diet-Induced Steatohepatitis by Suppressing Ferroptosis
- The m6A methyltransferase METTL3 in intervertebral disc degeneration: from molecular mechanisms to therapeutic potential
- Catalysis tuned for metabolic sensing: dynamics and mechanism of the RNA methyltransferase METTL16
- Nicotinamide N-methyltransferase couples inflammation and epigenetic remodelling to hepatic fibrosis
BibTeX
@article{han2026protein,
title = {{Protein arginine methyltransferase crosstalk: decoding the synergistic-antagonistic axis in cancer therapy.}},
author = {Yu Han and Lie Ma and Xiangyu Ma and Baiqu Huang},
journal = {Epigenetics \& chromatin},
year = {2026},
month = jul,
doi = {10.1186/s13072-026-00693-y},
url = {https://europepmc.org/article/MED/42908009},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Protein arginine methyltransferase crosstalk: decoding the synergistic-antagonistic axis in cancer therapy.
AU - Yu Han
AU - Lie Ma
AU - Xiangyu Ma
AU - Baiqu Huang
PY - 2026
DA - 2026/07/01
JO - Epigenetics & chromatin
DO - 10.1186/s13072-026-00693-y
UR - https://europepmc.org/article/MED/42908009
AB - Background Protein arginine methyltransferases (PRMTs) are abnormally expressed in various tumors and participate in multiple tumorigenic processes, including proliferation, metastasis, drug resistance, and metabolic reprogramming. However, in recent years, with the in-depth exploration of the functions of PRMTs and their associated tumorigenic mechanisms, the complex crosstalk relationships among different PRMTs have been increasingly highlighted. Different PRMTs may not only exhibit synergistic tumor-promoting effects but also demonstrate antagonistic effects in certain tumor biological functions. This makes the scientific and rational use of PRMT inhibitors a key factor for effective tumor suppression.Main body The review aims to provide a comprehensive overview of the functional roles of different PRMTs in tumors, with a particular focus on their cross-functional regulatory mechanisms within the complex regulatory networks of tumors. Meanwhile, it summarizes the current research progress on PRMT inhibitors and elaborates on some limitations associated with PRMT-targeted therapy. Through the integration and analysis of existing research findings, this review offers a novel perspective on the complex regulatory roles of different PRMTs jointly participating in biological functions.Conclusions Accumulating evidence suggests that implementing a multi-targeted intervention strategy for PRMTs and conducting stage-specific inhibition of PRMTs according to the progression stage of tumor development hold the potential to exert more significant therapeutic effects in the field of tumor treatment.
SN - 1756-8935
ER -